© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 15, 1240-1251,
August 2, 2000
© 2000 Oxford University Press
Cancer Surveillance Series: Non-Hodgkin's Lymphoma Incidence by Histologic Subtype in the United States From 1978 Through 1995
Affiliations of authors: F. D. Groves, S. S. Devesa, (Biostatistics Branch), M. S. Linet, L. B. Travis (Radiation Epidemiology Branch), Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD.
Correspondence to: Susan S. Devesa, Ph.D., National Institutes of Health, Executive Plaza South, Rm. 8048, 6120 Executive Blvd., MSC 7244, Bethesda, MD 20892-7244 (e-mail: devesas{at}exchange.nih.gov).
Background: Clinical investigations have shown prognostic heterogeneity within the non-Hodgkin's lymphomas (NHLs) according to histology, but few descriptive studies have considered NHLs by subgroup. Our purpose is to assess the demographic patterns and any notable increases in population-based rates of different histologic subgroups of NHL. Methods: Using data collected by the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute, we calculated incidence rates for the major clinicopathologic categories of NHL by age, race, sex, geographic area, and time period. Results: Among the 60 057 NHL cases diagnosed during the period from 1978 through 1995, total incidence (per 100 000 person-years) was 17.1 and 11.5 among white males and females, respectively, and 12.6 and 7.4 among black males and females, respectively. However, rates for follicular NHLs were two to three times greater among whites than among blacks, with little sex variation. Blacks demonstrated much higher incidence than whites for peripheral T-cell NHL, with the incidence rates higher in males than in females. For other NHL subgroups, the incidence rates for persons less than 60 years of age were generally higher among males than among females, with little racial difference; at older ages, the rates were higher among whites than among blacks, with little sex difference. High-grade NHL was the most rapidly rising subtype, particularly among males. Follicular NHL increased more rapidly in black males than in the other three race/sex groups. Overall, the broad categories of small lymphocytic, follicular, diffuse, high-grade, and peripheral T-cell NHL emerged as distinct entities with specific age, sex, racial, temporal, and geographic variations in rates. Conclusions: Findings from our large, population-based study reveal differing demographic patterns and incidence trends according to histologic group. Future descriptive and analytic investigations should evaluate NHL risks according to subtype, as defined by histology and new classification criteria.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. Shetty, A.P. Holt, W.-K. Syn, C.P. Fox, B. Gunson, D. Neil, and G. Haydon Haematological malignancies presenting with acute liver injury: a single-centre experience QJM, September 23, 2008; (2008) hcn121v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Bendandi Aiming at a Curative Strategy for Follicular Lymphoma CA Cancer J Clin, September 1, 2008; 58(5): 305 - 317. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. D. Sjo, E. Ralfkiaer, J. U. Prause, J. H. Petersen, J. Madsen, N. T. Pedersen, and S. Heegaard Increasing Incidence of Ophthalmic Lymphoma in Denmark from 1980 to 2005 Invest. Ophthalmol. Vis. Sci., August 1, 2008; 49(8): 3283 - 3288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Lee, P. M. Bracci, and E. A. Holly Non-Hodgkin Lymphoma in Women: Reproductive Factors and Exogenous Hormone Use Am. J. Epidemiol., August 1, 2008; 168(3): 278 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zhang, S. D. Sanjose, P. M. Bracci, L. M. Morton, R. Wang, P. Brennan, P. Hartge, P. Boffetta, N. Becker, M. Maynadie, et al. Personal Use of Hair Dye and the Risk of Certain Subtypes of Non-Hodgkin Lymphoma Am. J. Epidemiol., June 1, 2008; 167(11): 1321 - 1331. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Thieblemont, A. Grossoeuvre, R. Houot, F. Broussais-Guillaumont, G. Salles, C. Traulle, D. Espinouse, and B. Coiffier Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome Ann. Onc., April 1, 2008; 19(4): 774 - 779. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Yu, R. C. Blitzblau, R. H. Decker, D. M. Housman, and L. D. Wilson Analysis of Primary CD30+ Cutaneous Lymphoproliferative Disease and Survival From the Surveillance, Epidemiology, and End Results Database J. Clin. Oncol., March 20, 2008; 26(9): 1483 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Pulte, A. Gondos, and H. Brenner Ongoing Improvement in Outcomes for Patients Diagnosed as Having Non-Hodgkin Lymphoma From the 1990s to the Early 21st Century Arch Intern Med, March 10, 2008; 168(5): 469 - 476. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Koutros, Y. Zhang, Y. Zhu, S. T. Mayne, S. H. Zahm, T. R. Holford, B. P. Leaderer, P. Boyle, and T. Zheng Nutrients Contributing to One-Carbon Metabolism and Risk of Non-Hodgkin Lymphoma Subtypes Am. J. Epidemiol., February 1, 2008; 167(3): 287 - 294. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Smith, F. Jin, and I. Joshi Bortezomib Sensitizes Non Hodgkin's Lymphoma Cells to Apoptosis Induced by Antibodies to Tumor Necrosis Factor Related Apoptosis-Inducing Ligand (TRAIL) Receptors TRAIL-R1 and TRAIL-R2 Clin. Cancer Res., September 15, 2007; 13(18): 5528s - 5534s. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Thieblemont and B. Coiffier Lymphoma in Older Patients J. Clin. Oncol., May 10, 2007; 25(14): 1916 - 1923. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Grulich, C. M. Vajdic, and W. Cozen Altered Immunity as a Risk Factor for Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., March 1, 2007; 16(3): 405 - 408. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J H Mandel, M A Kelsh, P J Mink, D D Alexander, R M Kalmes, M Weingart, L Yost, and M Goodman Occupational trichloroethylene exposure and non-Hodgkin's lymphoma: a meta-analysis and review Occup. Environ. Med., September 1, 2006; 63(9): 597 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Moslehi, S. S. Devesa, C. Schairer, and J. F. Fraumeni Jr. Rapidly Increasing Incidence of Ocular Non-Hodgkin Lymphoma. J Natl Cancer Inst, July 5, 2006; 98(13): 936 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sandin, H. Hjalgrim, B. Glimelius, K. Rostgaard, E. Pukkala, and J. Askling Incidence of Non-Hodgkin's Lymphoma in Sweden, Denmark, and Finland from 1960 through 2003: an Epidemic That Was. Cancer Epidemiol. Biomarkers Prev., July 1, 2006; 15(7): 1295 - 1300. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Habermann, E. A. Weller, V. A. Morrison, R. D. Gascoyne, P. A. Cassileth, J. B. Cohn, S. R. Dakhil, B. Woda, R. I. Fisher, B. A. Peterson, et al. Rituximab-CHOP Versus CHOP Alone or With Maintenance Rituximab in Older Patients With Diffuse Large B-Cell Lymphoma J. Clin. Oncol., July 1, 2006; 24(19): 3121 - 3127. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Lim, S. Weinstein, D. Albanes, P. Pietinen, L. Teerenhovi, P. R. Taylor, J. Virtamo, and R. Stolzenberg-Solomon Dietary factors of one-carbon metabolism in relation to non-hodgkin lymphoma and multiple myeloma in a cohort of male smokers. Cancer Epidemiol. Biomarkers Prev., June 1, 2006; 15(6): 1109 - 1114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Clarke, D. M. Undurraga, P. J. Harasty, S. L. Glaser, L. M. Morton, and E. A. Holly Changes in cancer registry coding for lymphoma subtypes: reliability over time and relevance for surveillance and study. Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 630 - 638. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Irby, W. F. Anderson, D. E. Henson, and S. S. Devesa Emerging and widening colorectal carcinoma disparities between blacks and whites in the United States (1975-2002). Cancer Epidemiol. Biomarkers Prev., April 1, 2006; 15(4): 792 - 797. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Mitterlechner, M Fiegl, H Muhlbock, W Oberaigner, S Dirnhofer, and A Tzankov Epidemiology of non-Hodgkin lymphomas in Tyrol/Austria from 1991 to 2000 J. Clin. Pathol., January 1, 2006; 59(1): 48 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M. Morton, S. S. Wang, S. S. Devesa, P. Hartge, D. D. Weisenburger, and M. S. Linet Lymphoma incidence patterns by WHO subtype in the United States, 1992-2001 Blood, January 1, 2006; 107(1): 265 - 276. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Y. Pan, Y. Mao, A.-M. Ugnat, and and the Canadian Cancer Registries Epidemiology Re Physical Activity, Obesity, Energy Intake, and the Risk of Non-Hodgkin's Lymphoma: A Population-based Case-Control Study Am. J. Epidemiol., December 15, 2005; 162(12): 1162 - 1173. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Lim, M. Schenk, L. E. Kelemen, S. Davis, W. Cozen, P. Hartge, M. H. Ward, and R. Stolzenberg-Solomon Dietary Determinants of One-Carbon Metabolism and the Risk of Non-Hodgkin's Lymphoma: NCI-SEER Case-Control Study, 1998-2000 Am. J. Epidemiol., November 15, 2005; 162(10): 953 - 964. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. F. Skibola, P. M. Bracci, R. A. Paynter, M. S. Forrest, L. Agana, T. Woodage, K. Guegler, M. T. Smith, and E. A. Holly Polymorphisms and Haplotypes in the Cytochrome P450 17A1, Prolactin, and Catechol-O-Methyltransferase Genes and Non-Hodgkin Lymphoma Risk Cancer Epidemiol. Biomarkers Prev., October 1, 2005; 14(10): 2391 - 2401. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J.M. Ferreri, M. Ponzoni, M. Guidoboni, C. De Conciliis, A. G. Resti, B. Mazzi, A. A. Lettini, J. Demeter, S. Dell'Oro, C. Doglioni, et al. Regression of Ocular Adnexal Lymphoma After Chlamydia Psittaci-Eradicating Antibiotic Therapy J. Clin. Oncol., August 1, 2005; 23(22): 5067 - 5073. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. T. Swenson, J. E. Wooldridge, C. F. Lynch, V. L. Forman-Hoffman, E. Chrischilles, and B. K. Link Improved Survival of Follicular Lymphoma Patients in the United States J. Clin. Oncol., August 1, 2005; 23(22): 5019 - 5026. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Altieri, J. L. Bermejo, and K. Hemminki Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database Blood, July 15, 2005; 106(2): 668 - 672. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. W. Hance, W. F. Anderson, S. S. Devesa, H. A. Young, and P. H. Levine Trends in Inflammatory Breast Carcinoma Incidence and Survival: The Surveillance, Epidemiology, and End Results Program at the National Cancer Institute J Natl Cancer Inst, July 6, 2005; 97(13): 966 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. F. Modiano, M. Breen, R. C. Burnett, H. G. Parker, S. Inusah, R. Thomas, P. R. Avery, K. Lindblad-Toh, E. A. Ostrander, G. C. Cutter, et al. Distinct B-Cell and T-Cell Lymphoproliferative Disease Prevalence among Dog Breeds Indicates Heritable Risk Cancer Res., July 1, 2005; 65(13): 5654 - 5661. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Willemze, E. S. Jaffe, G. Burg, L. Cerroni, E. Berti, S. H. Swerdlow, E. Ralfkiaer, S. Chimenti, J. L. Diaz-Perez, L. M. Duncan, et al. WHO-EORTC classification for cutaneous lymphomas Blood, May 15, 2005; 105(10): 3768 - 3785. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lopez-Guillermo, L. Colomo, M. Jimenez, F. Bosch, N. Villamor, L. Arenillas, A. Muntanola, S. Montoto, E. Gine, D. Colomer, et al. Diffuse Large B-Cell Lymphoma: Clinical and Biological Characterization and Outcome According to the Nodal or Extranodal Primary Origin J. Clin. Oncol., April 20, 2005; 23(12): 2797 - 2804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. M. Morton, P. Hartge, T. R. Holford, E. A. Holly, B. C.H. Chiu, P. Vineis, E. Stagnaro, E. V. Willett, S. Franceschi, C. La Vecchia, et al. Cigarette Smoking and Risk of Non-Hodgkin Lymphoma: A Pooled Analysis from the International Lymphoma Epidemiology Consortium (InterLymph) Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 925 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Hartge, J. S. Colt, R. K. Severson, J. R. Cerhan, W. Cozen, D. Camann, S. H. Zahm, and S. Davis Residential Herbicide Use and Risk of Non-Hodgkin Lymphoma Cancer Epidemiol. Biomarkers Prev., April 1, 2005; 14(4): 934 - 937. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. B. Lens and J. A. Newton-Bishop An association between cutaneous melanoma and non-Hodgkin's lymphoma: pooled analysis of published data with a review Ann. Onc., March 1, 2005; 16(3): 460 - 465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. Smith, F. Jin, and I. Joshi Enhanced efficacy of therapy with antisense BCL-2 oligonucleotides plus anti-CD20 monoclonal antibody in scid mouse/human lymphoma xenografts Mol. Cancer Ther., December 1, 2004; 3(12): 1693 - 1699. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Purdue, D. G. Bassani, N. S. Klar, M. Sloan, N. Kreiger, and The Canadian Cancer Registries Epidemiology Resear Dietary Factors and Risk of Non-Hodgkin Lymphoma by Histologic Subtype: A Case-Control Analysis Cancer Epidemiol. Biomarkers Prev., October 1, 2004; 13(10): 1665 - 1676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Lech-Maranda, L. Baseggio, J. Bienvenu, C. Charlot, F. Berger, D. Rigal, K. Warzocha, B. Coiffier, and G. Salles Interleukin-10 gene promoter polymorphisms influence the clinical outcome of diffuse large B-cell lymphoma Blood, May 1, 2004; 103(9): 3529 - 3534. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. J. M. Ferreri, M. Guidoboni, M. Ponzoni, C. De Conciliis, S. Dell'Oro, K. Fleischhauer, L. Caggiari, A. A. Lettini, E. Dal Cin, R. Ieri, et al. Evidence for an Association Between Chlamydia psittaci and Ocular Adnexal Lymphomas J Natl Cancer Inst, April 21, 2004; 96(8): 586 - 594. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Turner, A. M. Hughes, A. Kricker, S. Milliken, A. Grulich, J. Kaldor, and B. Armstrong Use of the WHO lymphoma classification in a population-based epidemiological study Ann. Onc., April 1, 2004; 15(4): 631 - 637. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Hu, F. Ma, F. Collado-Mesa, and R. S. Kirsner Ultraviolet Radiation and Incidence of Non-Hodgkin's Lymphoma among Hispanics in the United States Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 59 - 64. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. Clarke, S. L. Glaser, R. F. Dorfman, P. M. Bracci, E. Eberle, and E. A. Holly Expert Review of Non-Hodgkin's Lymphomas in a Population-Based Cancer Registry: Reliability of Diagnosis and Subtype Classifications Cancer Epidemiol. Biomarkers Prev., January 1, 2004; 13(1): 138 - 143. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Chow and E. A. Holly Blood Transfusions and Non-Hodgkin's Lymphoma Epidemiol. Rev., December 1, 2002; 24(2): 269 - 279. [Full Text] [PDF]
|
|
|
|
|
|
J. R. Cerhan, C. M. Vachon, T. M. Habermann, S. M. Ansell, T. E. Witzig, P. J. Kurtin, C. A. Janney, W. Zheng, J. D. Potter, T. A. Sellers, et al. Hormone Replacement Therapy and Risk of Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Cancer Epidemiol. Biomarkers Prev., November 1, 2002; 11(11): 1466 - 1471. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Cerhan, C. A. Janney, C. M. Vachon, T. M. Habermann, N. E. Kay, J. D. Potter, T. A. Sellers, and A. R. Folsom Anthropometric Characteristics, Physical Activity, and Risk of Non-Hodgkin's Lymphoma Subtypes and B-Cell Chronic Lymphocytic Leukemia: A Prospective Study Am. J. Epidemiol., September 15, 2002; 156(6): 527 - 535. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Eltom, A. Jemal, S. M. Mbulaiteye, S. S. Devesa, and R. J. Biggar Trends in Kaposi's Sarcoma and Non-Hodgkin's Lymphoma Incidence in the United States From 1973 Through 1998 J Natl Cancer Inst, August 21, 2002; 94(16): 1204 - 1210. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Biagi and J. F. Seymour Insights into the molecular pathogenesis of follicular lymphoma arising from analysis of geographic variation Blood, May 29, 2002; 99(12): 4265 - 4275. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Chow and E. A. Holly Blood Transfusions as a Risk Factor for Non-Hodgkin's Lymphoma in the San Francisco Bay Area: A Population-based Study Am. J. Epidemiol., April 15, 2002; 155(8): 725 - 731. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Catassi, E. Fabiani, G. Corrao, M. Barbato, A. De Renzo, A. M. Carella, A. Gabrielli, P. Leoni, A. Carroccio, M. Baldassarre, et al. Risk of Non-Hodgkin Lymphoma in Celiac Disease JAMA, March 20, 2002; 287(11): 1413 - 1419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Vose, B. C.-H. Chiu, B. D. Cheson, J. Dancey, and J. Wright Update on Epidemiology and Therapeutics for Non-Hodgkin's Lymphoma Hematology, January 1, 2002; 2002(1): 241 - 262. [Abstract] [Full Text]
|
|
|
|
 |
|
 A. Giustina, M. Gola, M. Doga, and E. A. Rosei Primary Lymphoma of the Pituitary: An Emerging Clinical Entity J. Clin. Endocrinol. Metab., October 1, 2001; 86(10): 4567 - 4575. [Full Text] [PDF]
|
|
|
|
|
|
H. L. Howe, P. A. Wingo, M. J. Thun, L. A. G. Ries, H. M. Rosenberg, E. G. Feigal, and B. K. Edwards Annual Report to the Nation on the Status of Cancer (1973 Through 1998), Featuring Cancers With Recent Increasing Trends J Natl Cancer Inst, June 6, 2001; 93(11): 824 - 842. [Abstract] [Full Text] [PDF]
|
|